Skip to main content

Sensus Healthcare (SRTS) Receives a Buy from Roth MKM

Tipranks - Tipranks - Fri Aug 8, 2025

In a report released yesterday, Jason Wittes from Roth MKM maintained a Buy rating on Sensus Healthcare, with a price target of $10.00. The company’s shares closed yesterday at $5.35.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Wittes is a 4-star analyst with an average return of 4.3% and a 49.28% success rate. Wittes covers the Healthcare sector, focusing on stocks such as Orthofix, Zimmer Biomet Holdings, and Globus Medical.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sensus Healthcare with a $11.25 average price target, implying an 110.28% upside from current levels. In a report released on July 28, Lake Street also maintained a Buy rating on the stock with a $13.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $9.33 and a one-year low of $4.01. Currently, Sensus Healthcare has an average volume of 92.37K.

Read More on SRTS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).